These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35496814)

  • 1. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
    Kamath C; Brenner EJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
    Agrawal M; Zhang X; Brenner EJ; Ungaro RC; Kappelman MD; Colombel JF
    J Crohns Colitis; 2021 Nov; 15(11):1877-1884. PubMed ID: 33884425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis.
    Lee MH; Li HJ; Wasuwanich P; Kim SE; Kim JY; Jeong GH; Park S; Yang JW; Kim MS; Yon DK; Lee SW; Koyanagi A; Jacob L; Kim EY; Cheon JH; Shin JI; Smith L
    Rev Med Virol; 2023 Mar; 33(2):e2414. PubMed ID: 36504172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?
    Perdalkar S; Basthi Mohan P; Musunuri B; Rajpurohit S; Shetty S; Bhat K; Pai CG
    Int Immunopharmacol; 2023 Mar; 116():109597. PubMed ID: 36702073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
    Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE
    J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis.
    Alrashed F; Battat R; Abdullah I; Charabaty A; Shehab M
    BMJ Open Gastroenterol; 2021 Oct; 8(1):. PubMed ID: 34725056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease in the COVID-19 era.
    Kim KO; Jang BI
    Intest Res; 2022 Jan; 20(1):3-10. PubMed ID: 33525860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of biologics in inflammatory bowel disease patients with COVID-19.
    Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
    Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    Allez M; Fleshner P; Gearry R; Lakatos PL; Rubin DT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S774-S779. PubMed ID: 32722757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients.
    Ricciuto A; Lamb CA; Benchimol EI; Walker GJ; Kennedy NA; Kuenzig ME; Kaplan GG; Kappelman MD; Ungaro RC; Colombel JF; Brenner EJ; Agrawal M; Reinisch W; Griffiths AM; Sebastian S
    J Crohns Colitis; 2022 May; 16(4):591-600. PubMed ID: 34570886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
    Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.
    Meyer A; Semenzato L; Zureik M; Weill A; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2021 Jul; 54(2):160-166. PubMed ID: 34110040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IBD medications on COVID-19 outcomes: results from an international registry.
    Ungaro RC; Brenner EJ; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
    Gut; 2021 Apr; 70(4):725-732. PubMed ID: 33082265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.
    Richter V; Bermont A; Cohen DL; Broide E; Shirin H
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):267-273. PubMed ID: 34191758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors.
    Troncone E; Marafini I; Del Vecchio Blanco G; Di Grazia A; Monteleone G
    Clin Exp Gastroenterol; 2020; 13():131-139. PubMed ID: 32440190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing IBD in the COVID-19 era.
    Scalzo N; Ungaro RC
    Therap Adv Gastroenterol; 2023; 16():17562848231176450. PubMed ID: 37337593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.
    Alrashed F; Alasfour H; Shehab M
    JGH Open; 2022 Apr; 6(4):241-250. PubMed ID: 35475207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.